GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVO) » Definitions » FCF Margin %

Alvotech (Alvotech) FCF Margin % : -145.39% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alvotech's Free Cash Flow for the three months ended in Dec. 2023 was $-77.63 Mil. Alvotech's Revenue for the three months ended in Dec. 2023 was $53.39 Mil. Therefore, Alvotech's FCF Margin % for the quarter that ended in Dec. 2023 was -145.39%.

As of today, Alvotech's current FCF Yield % is -8.91%.

The historical rank and industry rank for Alvotech's FCF Margin % or its related term are showing as below:

ALVO' s FCF Margin % Range Over the Past 10 Years
Min: -731   Med: -392.26   Max: -129.51
Current: -392.26


During the past 5 years, the highest FCF Margin % of Alvotech was -129.51%. The lowest was -731.00%. And the median was -392.26%.

ALVO's FCF Margin % is ranked worse than
93.37% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.675 vs ALVO: -392.26


Alvotech FCF Margin % Historical Data

The historical data trend for Alvotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech FCF Margin % Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
-302.65 -129.51 -731.00 -435.26 -392.26

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -313.71 -630.40 -1,215.08 -717.71 -145.39

Competitive Comparison of Alvotech's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Alvotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alvotech's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alvotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Alvotech's FCF Margin % falls into.



Alvotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Alvotech's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-358.658/91.434
=-392.26 %

Alvotech's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-77.625/53.39
=-145.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alvotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Alvotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alvotech (Alvotech) Business Description

Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.